AIQ Raises Capital Without Disclosure Statement Amid Regulatory Compliance
Alternative Investment Trust (AIQ) has issued 7.39 million units at A$1.38 each, raising A$10.2 million from wholesale investors without a product disclosure statement. The capital raise aligns with AIQ’s adjusted net tangible asset value and complies with Corporations Act requirements.
- Placement of 7.39 million units completed
- Raised A$10.2 million at A$1.38 per unit
- Units issued to wholesale investors without disclosure
- Compliance with Corporations Act confirmed
- No excluded information disclosed
Wholesale Placement Raises A$10.2 Million
Alternative Investment Trust (ASX:AIQ) has successfully completed a placement of 7,391,304 units priced at A$1.38 each, raising approximately A$10.2 million. The units were issued to wholesale investors on 22 May 2026, marking a significant capital injection for the fund. This placement price matches AIQ’s adjusted net tangible asset (NTA) value as of April 2026, reflecting investor confidence in the fund’s underlying assets and valuation.
The capital raise was conducted without a product disclosure statement, leveraging exemptions under Part 7.9 of the Corporations Act 2001 (Cth). The responsible entity, One Managed Investment Funds Limited, confirmed full compliance with relevant provisions of the Corporations Act, including Chapters 2M, 674, and 674A, and stated that no excluded information exists that would materially affect the investment decision.
Strategic Capital Management Continues
This placement builds on AIQ’s recent capital management initiatives, including a substantial 23.4 million unit rights issue completed in September 2025, which significantly bolstered cash reserves. The latest raise will likely enhance AIQ’s ability to expand its exposure to key investments such as the WSS Master Fund, consistent with its strategy to grow and diversify its portfolio.
Investors should note that the placement units were issued exclusively to wholesale investors, a move that bypasses the need for unitholder approval under ASX Listing Rule 7.1. This approach allows AIQ to raise capital efficiently while maintaining compliance with regulatory frameworks.
Regulatory Compliance and Disclosure
The responsible entity’s notice under section 1012DA(5)(e) of the Corporations Act reiterates AIQ’s adherence to disclosure obligations despite the placement being made without a product disclosure statement. This compliance is crucial in maintaining market integrity and investor trust, especially given the size of the capital raise relative to the fund’s market capitalisation.
With no excluded information to disclose, the placement appears straightforward, with no material adverse events or changes impacting AIQ since previous announcements. This transparency should reassure investors monitoring the fund’s capital structure and investment outlook.
Bottom Line?
AIQ’s latest placement confirms ongoing capital flexibility but leaves open questions about the deployment of proceeds and impact on future distributions.
Questions in the middle?
- How will AIQ allocate the proceeds from this placement across its investment portfolio?
- What impact might the increased unit base have on AIQ’s future distribution policy?
- Will AIQ pursue further capital raises or consider alternative capital management strategies?
